125 related articles for article (PubMed ID: 23589069)
1. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
[TBL] [Abstract][Full Text] [Related]
2. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
3. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
4. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
5. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
6. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Kim HG; Han EH; Choi JH; Chung YC; Jeong HG
Toxicol Lett; 2011 May; 203(1):9-19. PubMed ID: 21354279
[TBL] [Abstract][Full Text] [Related]
7. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338
[TBL] [Abstract][Full Text] [Related]
8. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
9. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
Ho CC; Lai KC; Hsu SC; Kuo CL; Ma CY; Lin ML; Yang JS; Chung JG
Hum Exp Toxicol; 2011 Apr; 30(4):296-306. PubMed ID: 20498032
[TBL] [Abstract][Full Text] [Related]
10. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.
Liao YC; Shih YW; Chao CH; Lee XY; Chiang TA
J Agric Food Chem; 2009 Oct; 57(19):8933-41. PubMed ID: 19725538
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
Wang Y; Lazo JS
Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
[TBL] [Abstract][Full Text] [Related]
13. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
14. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
[TBL] [Abstract][Full Text] [Related]
15. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
[TBL] [Abstract][Full Text] [Related]
16. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
Tang F; Tang S; Guo X; Yang C; Jia K
Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
[TBL] [Abstract][Full Text] [Related]
17. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.
Walls CD; Iliuk A; Bai Y; Wang M; Tao WA; Zhang ZY
Mol Cell Proteomics; 2013 Dec; 12(12):3759-77. PubMed ID: 24030100
[TBL] [Abstract][Full Text] [Related]
20. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
